|Articles|May 20, 2020

Characterization and Formulation Screening of mAb and ADCs by High Throughput-DLS

Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.

Subscribe Now!

Trending on BioPharm International

Characterization and Formulation Screening of mAb and ADCs by High Throughput-DLS

Newsletter

Related Content

Particle Risk Mitigation in Biomanucturing

Executive Summary: Charge Detection Mass Spectrometry (CDMS): From Complexity to Clarity – A New Era in Biomolecular Analysis

Executive Summary: Supporting mRNA Development With Quantitative Expression Analysis

Applying Analytical Quality by Design Principles to Biopharma Method Development and Optimization

Executive Summary: Mastering Nitrosamines Analysis With Streamlined LC-MS/MS Solutions

Trending on BioPharm International

Advances in Continuous Manufacturing, Drug Delivery Lead CPHI Pharma Awards 2025

Establishing Risk Assessments for AI in Bio-Manufacturing

Strategic Shifts for Speed, Resilience, and Long-Term Sustainability in Biomanufacturing

EU Biopharma Strategy: Scaling Up to Tackle Funding Gaps and Drive Innovation

AI-Driven Organ-on-Chip Platforms Are Changing the Game in Bio/Pharma R&D